Dactinomycin (Compound)

Synonyms:DACTINOMYCIN, actinomycin D, Actinomycin C1, Actinomycin IV, Cosmegen, Meractinomycin, 50-76-0, Actinomycin I1, Dactinomycinum, Dilactone actinomycin D acid, ActD, Actinomycin X1, Oncostatin K, ACTINOMYCIN-D, ACT D, NCI-C04682, Dactinomycine [INN-French], Dactinomycinum [INN-Latin], Dactinomicina [INN-Spanish], Lyovac cosmegen, GNF-Pf-2290, Dactinomycin D, Chounghwamycin B, Actinomycin 7, DTXSID9020031, Actinomycin Aiv, Actinomycin I, MLS001424196, 1CC1JFE158, CHEBI:27666, Actinomycin X 1, Actinomycin A IV, Acto-D, NSC-3053, Actinomycin C(sub1), Dilactone actinomycindioic D acid, NCGC00161622-02, Actinomycin I(sub 1), SMR000469227, Actinomycin 11 cosmegen, Cosmegen Lyovac, Lyovac-Cosmegen, CCRIS 9, DTXCID5031, 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide, HSDB 3220, Dactinomicina, Dactinomycine, Actinomycindioic D acid, dilactone, Antibiotic from Streptomyces parvullus, Actinomycin-(threo-val-pro-sar-meval), CAS-50-76-0, ACT [antibiotic], X 97, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide, MFCD00005033, AD (VAN), GNF-PF-1977, NSC3053, UNII-1CC1JFE158, Glycopeptide, 4a, 2-amino-4,6-dimethyl-3-oxo-N,N'-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide, NSC 3053, Dactinomycin [USAN:USP:INN:BAN], EINECS 200-063-6, AI3-26374, DACTINOMYCIN [MI], DACTINOMYCIN [INN], UPCMLD-DP055, DACTINOMYCIN [HSDB], DACTINOMYCIN [USAN], SCHEMBL3844, ACTINOMYCIN D [JAN], CHEMBL1554, DACTINOMYCIN [VANDF], ACTINOMYCIN D [IARC], DACTINOMYCIN [MART.], DACTINOMYCIN [USP-RS], DACTINOMYCIN [WHO-DD], DACTINOMYCIN [WHO-IP], cid_457193, ACTINOMYCIN D [WHO-IP], UPCMLD-DP055:001, UPCMLD-DP055:002, BDBM43866, DACTINOMYCIN [ORANGE BOOK], HMS2052O17, DACTINOMYCIN [USP MONOGRAPH], Tox21_111997, Tox21_202482, BDBM50089528, s8964, DACTINOMYCINUM [WHO-IP LATIN], AKOS030228553, Tox21_111997_1, CCG-101134, DB00970, NC00384, NCGC00090796-01, NCGC00161622-01, NCGC00260031-01, NCGC00271789-02, 3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-, BP-25384, Specific stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)-bis(carbonylimino(2-hydroxypropylidene)carbonyliminoisobutylidenecarbonyl-1,2-pyrrolidinediylcarbonyl(methylimino)methylenecarbonyl))bis(N-methyl-L-valine) dilactone, Stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis(carbonylimino(2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl)imino(2-(1-methylethyl)-1-oxo-2,1-ethanediyl)-1,2-pyrrolidinediylcarbonyl(methylimino) (1-oxo-2,1-ethanediyl)))bis(N-methyl-L-valine)di-xi-lactone, AB00514445-05, EN300-7480748, Q186127, SR-01000763161, SR-01000763161-4, Actinomycin D, from Streptomyces sp., >=95% (HPLC), Actinomycin D, from Streptomyces sp., ~98% (HPLC), BRD-K70578146-001-01-8, BRD-K70578146-001-04-2, Dactinomycin, United States Pharmacopeia (USP) Reference Standard, Actinomycin D, for fluorescence, >=90% (HPLC), from Streptomyces sp., Actinomycin D, from Streptomyces sp., suitable for cell culture, >=95%, 1-N,9-N-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide, 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis-[(18aS)-10c,14,17-trimethyl-5,8,12,15,18-pentaoxo-6c,13t-di(propan-2-yl)-18ar-hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-9c-yl]-3H-phenoxazine-1,9-dicarboxamide, 2-amino-4,6-dimethyl-3-oxo-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide, 2-amino-N,N''''''''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide, 2-amino-N,N''''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide, 2-amino-N,N''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide, 2-amino-N1,N9-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide, 2-azanyl-4,6-dimethyl-3-oxidanylidene-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentakis(oxidanylidene)-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide, 3H-PHENOXAZINE-1,9-DICARBOXAMIDE, 2-AMINO-N,N'-BIS(HEXADECAHYDRO-6,13-DIISOPROPYL-2,5,9-TRIMETHYL-1,4,7,11,14-PENTAOXO-1H-PYRROLO(2,1-I)(1,4,7,10,13)OXATETRAAZACYCLOHEXADECIN-10-YL)-4,6-DIMETHYL-3-OXO-, N,N'-((2-AMINO-4,6-DIMETHYL-3-OXO-3H-PHENOXAZINE-1,9-DIYL)-BIS(CARBONYLIMINO(2-HYDROXYPROPYLIDENE)CARBONYLIMINOISOBUTYLIDENECARBONYL-1,2-PYRROLIDINEDIYLCARBONYL(METHYLIMINO)METHYLENECARBONYL))BIS(N-METHYL-L-VALINE) DILACTONE, N1,N9-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

Pubchem:PUBCHEM:457193

Id:1f83dc3f-ae2f-5812-8fc4-9bda12d510bb

Description:nan